Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,189,956
+$2,151,977 QoQ
Shares Held
18,927
+140.2% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#252
of 768 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sanctuary Advisors, LLC holds $25,944,542 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
272,749 | $4,331,254 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
105,645 | $3,662,712 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
18,927 | $3,189,956 | |
| 4 | HLN |
Haleon plc
|
340,028 | $3,172,461 | |
| 5 | ZTS |
Zoetis Inc.
|
43,902 | $3,154,797 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
74,865 | $2,536,426 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
13,756 | $1,138,721 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
1,695 | $918,401 |
All Filings in NBIX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,189,956 | 18,927 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,037,979 | 7,879 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,198,463 | 8,450 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $555,343 | 3,956 | Shares | Sole | 2026-01-06 | |
| 2025-06-30 | $831,062 | 6,612 | Shares | Sole | 2026-01-06 | |
| 2025-03-31 | $437,533 | 3,956 | Shares | Sole | 2026-01-06 | |
| 2024-12-31 | $1,118,071 | 8,191 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $881,317 | 7,649 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $516,400 | 3,751 | Shares | Sole | 2024-09-05 | |
| No filing history on record for this holder in this stock. | ||||||